TY - JOUR
T1 - Transculturalization of a diabetes-specific nutrition algorithm
T2 - Asian application
AU - Su, Hsiu Yueh
AU - Tsang, Man Wo
AU - Huang, Shih-Yi
AU - Mechanick, Jeffrey I.
AU - Sheu, Wayne Huey Herng
AU - Marchetti, Albert
N1 - Funding Information:
H.-Y. Su: has received financial support from Abbott Nutrition, Pfizer, GlaxoSmithKline, and Bayer for consultancy; M.-W. Tsang: none; S.-Y. Huang: none; J.I. Mechanick: has received financial support for the development of educational presentations from Abbott Nutrition. He has received financial support for consultancy and for writing and reviewing the manuscript from Abbott Nutrition. He has received fees for participation in review activities such as data monitoring boards, statistical analysis, and end point committees from Abbott Nutrition International. He has received funding for travel and accommodations from Abbott Nutrition; W.H-H. Sheu: has received financial support for consultancy from Abbott Nutrition, Pfizer, Glaxo-SmithKline, and Bayer; A. Marchetti: has received financial support for research and the development of educational materials from BMS, Abbott Nutrition, Takeda, and Eli Lilly; O. Hamdy: has received financial support for consultancy from Abbott Nutrition. He has received financial support as a speaker for Amylin/Eli Lilly.
Funding Information:
Disclosure Conflicts of interest: The development of this article was funded by Abbott Nutrition.
PY - 2012/4
Y1 - 2012/4
N2 - The prevalence of type 2 diabetes (T2D) in Asia is growing at an alarming rate, posing significant clinical and economic risk to health care stakeholders. Commonly, Asian patients with T2D manifest a distinctive combination of characteristics that include earlier disease onset, distinct pathophysiology, syndrome of complications, and shorter life expectancy. Optimizing treatment outcomes for such patients requires a coordinated inclusive care plan and knowledgeable practitioners. Comprehensive management starts with medical nutrition therapy (MNT) in a broader lifestyle modification program. Implementing diabetes-specificMNTin Asia requires high-quality and transparent clinical practice guidelines (CPGs) that are regionally adapted for cultural, ethnic, and socioeconomic factors. Respected CPGs for nutrition and diabetes therapy are available from prestigious medical societies. For cost efficiency and effectiveness, health care authorities can select these CPGs for Asian implementation following abridgement and cultural adaptation that includes: defining nutrition therapy in meaningful ways, selecting lower cutoff values for healthy body mass indices and waist circumferences (WCs), identifying the dietary composition of MNT based on regional availability and preference, and expanding nutrition therapy for concomitant hypertension, dyslipidemia, overweight/obesity, and chronic kidney disease. An international task force of respected health care professionals has contributed to this process. To date, task force members have selected appropriate evidence-based CPGs and simplified them into an algorithm for diabetes-specific nutrition therapy. Following cultural adaptation, Asian and Asian-Indian versions of this algorithmic tool have emerged. The Asian version is presented in this report.
AB - The prevalence of type 2 diabetes (T2D) in Asia is growing at an alarming rate, posing significant clinical and economic risk to health care stakeholders. Commonly, Asian patients with T2D manifest a distinctive combination of characteristics that include earlier disease onset, distinct pathophysiology, syndrome of complications, and shorter life expectancy. Optimizing treatment outcomes for such patients requires a coordinated inclusive care plan and knowledgeable practitioners. Comprehensive management starts with medical nutrition therapy (MNT) in a broader lifestyle modification program. Implementing diabetes-specificMNTin Asia requires high-quality and transparent clinical practice guidelines (CPGs) that are regionally adapted for cultural, ethnic, and socioeconomic factors. Respected CPGs for nutrition and diabetes therapy are available from prestigious medical societies. For cost efficiency and effectiveness, health care authorities can select these CPGs for Asian implementation following abridgement and cultural adaptation that includes: defining nutrition therapy in meaningful ways, selecting lower cutoff values for healthy body mass indices and waist circumferences (WCs), identifying the dietary composition of MNT based on regional availability and preference, and expanding nutrition therapy for concomitant hypertension, dyslipidemia, overweight/obesity, and chronic kidney disease. An international task force of respected health care professionals has contributed to this process. To date, task force members have selected appropriate evidence-based CPGs and simplified them into an algorithm for diabetes-specific nutrition therapy. Following cultural adaptation, Asian and Asian-Indian versions of this algorithmic tool have emerged. The Asian version is presented in this report.
KW - Asians
KW - Diabetes
KW - Diabetes-specific formula
KW - Medical nutrition therapy
UR - http://www.scopus.com/inward/record.url?scp=84862776812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862776812&partnerID=8YFLogxK
U2 - 10.1007/s11892-012-0252-0
DO - 10.1007/s11892-012-0252-0
M3 - Article
C2 - 22311609
AN - SCOPUS:84862776812
SN - 1534-4827
VL - 12
SP - 213
EP - 219
JO - Current Diabetes Reports
JF - Current Diabetes Reports
IS - 2
ER -